Development, in-vitro and ex-vivo evaluation of HPMC E-15/Xanthan gum mucoadhesive buccal patch of telmisartan

Hattaraki Shashank  Shivanand; Preethi G.B; Shashank K; Subham  Roy; Suhasini  Rendale

doi:10.69857/joapr.v14i3.1887

Authors

Hattaraki Shashank Shivanand Department of Pharmaceutics, KLE College of Pharmacy, Rajajinagar, Bengaluru 560010, KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India
Preethi G.B Department of Pharmaceutics KLE College of Pharmacy, Bengaluru
Shashank K Department of Pharmaceutics, KLE College of Pharmacy, Rajajinagar, Bengaluru 560010, KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India
Subham Roy Department of Pharmaceutics, KLE College of Pharmacy, Rajajinagar, Bengaluru 560010, KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India
Suhasini Rendale Department of Pharmaceutics, KLE College of Pharmacy, Rajajinagar, Bengaluru 560010, KLE Academy of Higher Education and Research, Belagavi 590010, Karnataka, India

DOI:

https://doi.org/10.69857/joapr.v14i3.1887

Keywords:

Telmisartan, Mucoadhesive Buccal patch, HPMC E-15, Xanthan gum, Kolliphor RH 40

Abstract

Background: Telmisartan, an antihypertensive drug, exhibits poor aqueous solubility and low oral bioavailability due to extensive hepatic first-pass metabolism. Buccal delivery offers a potential alternative route to bypass first-pass metabolism and achieve sustained drug release for better blood pressure control, particularly in nocturnal hypertension. The aim of the work was to formulate and evaluate a Telmisartan mucoadhesive buccal patch for sustained drug delivery. Methodology: Telmisartan solid dispersion with Kolliphor RH 40 was prepared by solvent evaporation, and mucoadhesive buccal patches (T1–T9) were formulated by solvent casting and optimized using a 3² full factorial design with Xanthan gum (A) and HPMC E15 (B) at three levels each, followed by evaluation of physicochemical properties, mucoadhesion, swelling, drug release, permeation, and drug–excipient compatibility by FT-IR, DSC, and XRD. Results & Discussion: Based on statistical analysis, it was observed that Xanthan gum and HPMC E15 significantly (p < 0.05) affected all the responses, and T9 was selected as the optimized formulation with a desirable swelling index of 331% and strong mucoadhesive strength of 28.5 ± 0.5 g. Optimized formulation T9 showed sustained drug release of 94.87%, and ex vivo permeation of 1.773 ± 0.033 mg/cm²) with a flux of 0.221 mg/cm²/h). Conclusion: The optimized T9 patch exhibited enhanced swelling, adhesion, sustained release, and permeation, suggesting its potential as an effective alternative for managing nocturnal hypertension.

Downloads

Download data is not yet available.

References

Wibowo A, Hastuti P, Susanti V. The association of angiotensin converting enzyme I/D and angiotensinogen M235T polymorphism genes with essential hypertension: A meta-analysis. Open Access Maced J Med Sci, 9(F), 739–746 (2021) https://doi.org/10.3889/oamjms.2021.7628

Guerrero-García C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Drugs Context, 7, 212531 (2018) https://doi.org/10.7573/dic.212531

Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol, 16(4), 223–237 (2020) https://doi.org/10.1038/s41581-019-0244-2

Hanif M, Zaman M, Chaurasiya V. Polymers used in buccal film: A review. Des Monomers Polym, 18(2), 105–111 (2015) https://doi.org/10.1080/15685551.2014.971389

Abdalla M, Goldsmith J, Muntner P, Diaz KM, Reynolds K, Schwartz JE, Shimbo D. Is isolated nocturnal hypertension a reproducible phenotype? Am J Hypertens, 29(1), 33–38 (2016) https://doi.org/10.1093/ajh/hpv058

Sabareesh M, Suma P, Venkata Ravi M, Balaji A. Nanoparticles loaded mucoadhesive buccal patches: Review. J Pharm Res Int, 34(46B), 24–38 (2022) https://doi.org/10.9734/JPRI/2022/v34i46B36388

Montenegro-Nicolini M, Morales JO. Overview and potential of buccal mucoadhesive films as drug delivery systems for biologics. AAPS PharmSciTech, 18, 3–14 (2017) https://doi.org/10.1208/s12249-016-0525-z

Şenel S, Rathbone MJ, Cansız M, Pather I. Recent developments in buccal and sublingual delivery systems. Expert Opin Drug Deliv, 9(6), 615–628 (2012) https://doi.org/10.1517/17425247.2012.676040

Malpure DR, Deore SL. Buccal mucoadhesive films: A review. Syst Rev Pharm, 8(1) (2017) https://doi.org/10.5530/srp.2017.1.7

Shipp L, Liu F, Kerai-Varsani L, Okwuosa TC. Buccal films: A review of therapeutic opportunities, formulations and relevant evaluation approaches. J Control Release, 352, 1071–1092 (2022) https://doi.org/10.1016/j.jconrel.2022.10.058

Vikhe S, Sukhadhane P, Vikhe R, Bornare SL, Dhavane SS. Antidiabetic effects of Semecarpus anacardium leaf extracts in streptozotocin-induced diabetes in rats. Journal of Applied Pharmaceutical Research, 12(6), 144–158 (2024) https://doi.org/10.69857/joapr.v12i6.736

Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev, 57(11), 1666–1691 (2005) https://doi.org/10.1016/j.addr.2005.07.003

Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm, 77(2), 187–199 (2011) https://doi.org/10.1016/j.ejpb.2010.11.023

Jacob S, Nair AB, Shah J. An updated overview of the emerging role of patch and film-based buccal delivery systems. Pharmaceutics, 13(8), 1206 (2021) https://doi.org/10.3390/pharmaceutics13081206

Dubey A, Kharia AA, Chatterjee DP. Enhancement of aqueous solubility and dissolution of telmisartan using solid dispersion technique. Int J Pharm Sci Res, 5(10), 4478–4485 (2014) https://doi.org/10.13040/IJPSR.0975-8232.5(10).4478-85

Patel K, Patel A, Dave J, Patel C. Absorbance correction method for estimation of telmisartan and metoprolol succinate in combined tablet dosage forms. Pharm Methods, 3(2), 106–111 (2012) https://doi.org/10.4103/2229-4708.103891

Deppe S, Böger RH, Weiss J, Benndorf RA. Telmisartan: A review of its pharmacodynamic and pharmacokinetic properties. Expert Opin Drug Metab Toxicol, 6(7), 863–871 (2010) https://doi.org/10.1517/17425255.2010.494597

Sharpe M, Jarvis B, Goa KL. Telmisartan: A review of its use in hypertension. Drugs, 61(10), 1501–1529 (2001) https://doi.org/10.2165/00003495-200161100-00009

Isaac J, Ganguly S, Ghosh A. Co-milling of telmisartan with poly(vinyl alcohol): An alkalinizer-free green approach to ensure its bioavailability. Eur J Pharm Biopharm, 101, 43–52 (2016) https://doi.org/10.1016/j.ejpb.2016.01.016

Mehta S, Joseph NM, Feleke F, Palani S. Improving solubility of BCS class II drugs using solid dispersion: A review. J Drug Deliv Ther, 4(3), 7–13 (2014) https://doi.org/10.22270/jddt.v4i3.844

Jadhav V, Kashid P, Otari K, Yadav M. Solubility enhancement by solid dispersion method: An overview. Asian J Pharm Res Dev, 12(4) (2024) https://doi.org/10.22270/ajprd.v12i4.1450

Dalvi PB, Gerange AB. Solid dispersion: Strategy to enhance solubility. J Drug Deliv Ther, 5(2), 20–28 (2015) https://doi.org/10.22270/jddt.v5i2.1060

Sharma V, Pathak K. Modified xanthan gum as a hydrophilic disintegrating excipient for rapidly disintegrating tablets of roxithromycin. Indian J Pharm Educ Res, 47(4), 79–87 (2013) https://doi.org/10.5530/ijper.47.4.11

Newton AM, Lakshmanan P. Effect of HPMC-E15 LV premium polymer on release profile and compression characteristics of chitosan/pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile. Recent Pat Drug Deliv Formul, 8(1), 46–62 (2014) https://doi.org/10.2174/1872211308666140225143926

Newton AM, Prabakaran L, Jayaveera KN. Formulation development, optimization, and study on drug release kinetics of Eudragit® L100-HPMC E15 LV mixed film-coated colon-targeted mesalamine tablets. Asian J Pharm, 6(3) (2012) https://doi.org/10.22377/ajp.v6i3.53

Blajovan R, Ledeţi I, Vlase G, Ledeţi A, Vlase T. Study of thermally induced excipient–excipient interactions: Polyvinyl alcohol and polyvinylpyrrolidone with other pharmaceutical excipients. J Therm Anal Calorim, 126, 171–179 (2016) https://doi.org/10.1007/s10973-016-5348-3

Park J, Cho W, Cha KH, Ahn J, Han K, Hwang SJ. Solubilization of the poorly water-soluble drug telmisartan using supercritical anti-solvent process. Int J Pharm, 441(1–2), 50–53 (2013) https://doi.org/10.1016/j.ijpharm.2012.12.020

Rao M, Bajaj A, Khole I, Munjapara G, Trotta F. In vitro and in vivo evaluation of β-cyclodextrin-based nanosponges of telmisartan. J Incl Phenom Macrocycl Chem, 77, 135–145 (2013) https://doi.org/10.1007/s10847-012-0224-7

Shiledar RR, Tagalpallewar AA, Kokare CR. Formulation and in vitro evaluation of xanthan gum-based bilayered mucoadhesive buccal patches of zolmitriptan. Carbohydr Polym, 101, 1234–1242 (2014) https://doi.org/10.1016/j.carbpol.2013.10.072

Kraisit P, Limmatvapirat S, Luangtana-Anan M, Sriamornsak P. Buccal administration of mucoadhesive blend films saturated with propranolol loaded nanoparticles. Asian J Pharm Sci, 13(1), 34–43 (2018) https://doi.org/10.1016/j.ajps.2017.07.006

Kayande K. Formulation, optimization, and evaluation of bioadhesive xanthan gum based buccal patch for sustained delivery of ropinirole hydrochloride. Asian J Pharm, 15(1) (2021) https://doi.org/10.22377/ajp.v15i1.3956

Gupta KR, Pounikar AR, Umekar MJ. Drug–excipient compatibility testing protocols and characterization: A review. Asian J Chem Sci, 6(3), 1–22 (2019) https://doi.org/10.9734/ajocs/2019/v6i319000

Yedurkar P, Dhiman MK, Petkar K, Sawant K. Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: In vitro, pharmacokinetic and pharmacodynamic investigations. J Microencapsul, 29(2), 126–137 (2012) https://doi.org/10.3109/02652048.2011.630109

Hasnain MS, Guru PR, Rishishwar P, Ali S, Ansari MT, Nayak AK. Atenolol-releasing buccal patches made of Dillenia indica L. fruit gum: Preparation and ex vivo evaluations. SN Appl Sci, 2, 1756 (2020) https://doi.org/10.1007/s42452-019-1756-x

Semalty M, Semalty A, Kumar G. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian J Pharm Sci, 70(1), 43–48 (2008) https://doi.org/10.4103/0250-474X.40330

Patil S, Bhargav S. Formulation and evaluation of a bifonazole-loaded chitosan-honey invasomal hydrogel for enhanced topical antifungal activity. Journal of Applied Pharmaceutical Research, 13(4), 36–44 (2025) https://doi.org/10.69857/joapr.v13i4.1301

El-Maghraby GM, Abdelzaher MM. Formulation and evaluation of simvastatin buccal film. J Appl Pharm Sci, 5(4), 70–77 (2015) https://doi.org/10.7324/JAPS.2015.50412

Tran PH, Tran HT, Lee BJ. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J Control Release, 129(1), 59–65 (2008) https://doi.org/10.1016/j.jconrel.2008.04.001

Chella N, Narra N, Rama Rao T. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan. J Drug Deliv, 2014, 692793 (2014) https://doi.org/10.1155/2014/692793

Khanfar M, Al-Remawi M, Al-Akayleh F, Hmouze S. Preparation and evaluation of co-amorphous formulations of telmisartan-amino acids as a potential method for solubility and dissolution enhancement. AAPS PharmSciTech, 22, 1–13 (2021) https://doi.org/10.1208/s12249-021-01952-9

Zhong L, Zhu X, Luo X, Su W. Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation. AAPS PharmSciTech, 14, 541–550 (2013) https://doi.org/10.1208/s12249-013-9937-1

Bhattarai M, Gupta AK. Fast dissolving oral films: A novel trend to oral drug delivery system. Sunsari Tech Coll J, 2(1), 58–68 (2015) https://doi.org/10.3126/stcj.v2i1.14802

Abu-Huwaij R, Obaidat RM, Sweidan K, Al-Hiari Y. Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches loaded with nicotine. AAPS PharmSciTech, 12(1), 21–27 (2011) https://doi.org/10.1208/s12249-010-9534-5

Mircioiu C, Voicu V, Anuţa V, Tudose A, Celia C, Paolino D, Fresta M, Sandulovici R, Mircioiu I. Mathematical modeling of release kinetics from supramolecular drug delivery systems. Pharmaceutics, 11(3), 140 (2019) https://doi.org/10.3390/pharmaceutics11030140

Verma N, Chattopadhyay P. Effect of novel mucoadhesive buccal patches of carvedilol on isoprenaline-induced tachycardia. J Adv Pharm Technol Res, 5(2), 96–103 (2014) https://doi.org/10.4103/2231-4040.133436

Devi JR, Das T, Kalita B, Sahariah BJ. Design and optimization of chitosan microspheres loaded with green tea phytosomes for sustained release. Journal of Applied Pharmaceutical Research, 13(5), 74–90 (2025) https://doi.org/10.69857/joapr.v13i5.1188

Yildiz Pekoz A, Erdal MS, Okyar A, Ocak M, Tekeli F, Kaptan E, Sagirli O, Araman A. Preparation and in vivo evaluation of dimenhydrinate buccal mucoadhesive films with enhanced bioavailability. Drug Dev Ind Pharm, 42(6), 916–925 (2016) https://doi.org/10.3109/03639045.2015.1091470

Singh S, Jain S, Muthu MS, Tiwari S, Tilak R. Preparation and evaluation of buccal bioadhesive films containing clotrimazole. AAPS PharmSciTech, 9, 660–667 (2008) https://doi.org/10.1208/s12249-008-9083-3

Al-Japairai KA, Alkhalidi HM, Mahmood S, Almurisi SH, Doolaanea AA, Al-Sindi TA, Chatterjee B. Lyophilized amorphous dispersion of telmisartan in a combined carrier-alkalizer system: Formulation development and in vivo study. ACS Omega, 5(50), 32466–32480 (2020) https://doi.org/10.1021/acsomega.0c04588

Perioli L, Ambrogi V, Rubini D, Giovagnoli S, Ricci M, Blasi P, Rossi C. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release, 95(3), 521–533 (2004) https://doi.org/10.1016/j.jconrel.2003.12.018

Pawar O, Godge R, Shinde G, Barde K, Vikhe A. Design, development, and optimization of mucoadhesive buccal films of ganaxolone for enhanced bioavailability. Journal of Applied Pharmaceutical Research, 13(2), 95–107 (2025) https://doi.org/10.69857/joapr.v13i2.943

Kumar C, Nanda A. Novel microwave-assisted solid dispersion technology enhances piroxicam dissolution and therapeutic efficacy: An in vitro and in vivo study. Journal of Applied Pharmaceutical Research, 13(1), 49–61 (2025) https://doi.org/10.69857/joapr.v13i1.921

Kyaw Oo M, Mandal UK, Chatterjee B. Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design. Pharm Dev Technol, 22(1), 2–12 (2017) https://doi.org/10.3109/10837450.2015.1116568

Jaouen V, Brayner R, Lantiat D, Steunou N, Coradin T. In situ growth of gold colloids within alginate films. Nanotechnology, 21(18), 185605 (2010) https://doi.org/10.1088/0957-4484/21/18/185605

Rossi S, Ferrari F, Bonferoni MC, Caramella C. Characterization of chitosan hydrochloride-mucin rheological interaction: Influence of polymer concentration and polymer:mucin weight ratio. Eur J Pharm Sci, 12(4), 479–485 (2001) https://doi.org/10.1016/S0928-0987(00)00194-9

Erdal MS, Gürbüz A, Tan SB, Güngör S, Özsoy Y. In vitro skin permeation and antifungal activity of naftifine microemulsions. Turk J Pharm Sci, 17(1), 43–50 (2020) https://doi.org/10.4274/tjps.galenos.2018.87699

Hesaraki S, Barounian MH, Borhan S, Shahrezayee M, Nezafati N. Controlled release of a non-steroidal anti-inflammatory drug from a photocurable polymeric calcium phosphate cement. J Biomater Sci Polym Ed, 20, 1–8 (2023) https://doi.org/10.1080/09205063.2023.2193495